A citation-based method for searching scientific literature

Denise Haslinger, Regina Waltes, Afsheen Yousaf, Silvia Lindlar, Ines Schneider, Chai K Lim, Meng-Miao Tsai, Boyan K Garvalov, Amparo Acker-Palmer, Nicolas Krezdorn, Björn Rotter, Till Acker, Gilles J Guillemin, Simone Fulda, Christine M Freitag, Andreas G Chiocchetti. Mol Autism 2018
Times Cited: 14







List of co-cited articles
103 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.
Marwan Shinawi, Pengfei Liu, Sung-Hae L Kang, Joseph Shen, John W Belmont, Daryl A Scott, Frank J Probst, William J Craigen, Brett H Graham, Amber Pursley,[...]. J Med Genet 2010
324
35

Association between microdeletion and microduplication at 16p11.2 and autism.
Lauren A Weiss, Yiping Shen, Joshua M Korn, Dan E Arking, David T Miller, Ragnheidur Fossdal, Evald Saemundsen, Hreinn Stefansson, Manuel A R Ferreira, Todd Green,[...]. N Engl J Med 2008
28

Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity.
Chai K Lim, Musthafa M Essa, Roberta de Paula Martins, David B Lovejoy, Ayse A Bilgin, Mostafa I Waly, Yahya M Al-Farsi, Marwan Al-Sharbati, Mohammed A Al-Shaffae, Gilles J Guillemin. Autism Res 2016
44
28

TBX6 null variants and a common hypomorphic allele in congenital scoliosis.
N Wu, X Ming, J Xiao, Z Wu, X Chen, M Shinawi, Y Shen, G Yu, J Liu, H Xie,[...]. N Engl J Med 2015
151
21

Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus.
Sébastien Jacquemont, Alexandre Reymond, Flore Zufferey, Louise Harewood, Robin G Walters, Zoltán Kutalik, Danielle Martinet, Yiping Shen, Armand Valsesia, Noam D Beckmann,[...]. Nature 2011
268
21

A new highly penetrant form of obesity due to deletions on chromosome 16p11.2.
R G Walters, S Jacquemont, A Valsesia, A J de Smith, D Martinet, J Andersson, M Falchi, F Chen, J Andrieux, S Lobbens,[...]. Nature 2010
320
21

KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant.
Christelle Golzio, Jason Willer, Michael E Talkowski, Edwin C Oh, Yu Taniguchi, Sébastien Jacquemont, Alexandre Reymond, Mei Sun, Akira Sawa, James F Gusella,[...]. Nature 2012
240
21

Kynurenine Pathway in Autism Spectrum Disorders in Children.
Vesna Bryn, Robert Verkerk, Ola H Skjeldal, Ola Didrik Saugstad, Heidi Ormstad. Neuropsychobiology 2017
23
21


Physiological and pathophysiological roles of NAMPT and NAD metabolism.
Antje Garten, Susanne Schuster, Melanie Penke, Theresa Gorski, Tommaso de Giorgis, Wieland Kiess. Nat Rev Endocrinol 2015
250
21

Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors.
Sara Duarte-Pereira, Isabel Pereira-Castro, Sarah S Silva, Mariana Gonçalves Correia, Célia Neto, Luís Teixeira da Costa, António Amorim, Raquel M Silva. Oncotarget 2016
33
21

Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer.
Deepak Sampath, Tanja S Zabka, Dinah L Misner, Thomas O'Brien, Peter S Dragovich. Pharmacol Ther 2015
142
21

The NAD metabolome--a key determinant of cancer cell biology.
Alberto Chiarugi, Christian Dölle, Roberta Felici, Mathias Ziegler. Nat Rev Cancer 2012
356
21

Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells.
Tove Ullmark, Giorgia Montano, Linnea Järvstråt, Helena Jernmark Nilsson, Erik Håkansson, Kristina Drott, Björn Nilsson, Karina Vidovic, Urban Gullberg. Biochem Biophys Res Commun 2017
14
21

NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling.
Sudhir Chowdhry, Ciro Zanca, Utkrisht Rajkumar, Tomoyuki Koga, Yarui Diao, Ramya Raviram, Feng Liu, Kristen Turner, Huijun Yang, Elizabeth Brunk,[...]. Nature 2019
62
21

Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study.
Alain Ravaud, Thomas Cerny, Catherine Terret, Jantien Wanders, Binh Nguyen Bui, Dagmar Hess, Jean-Pierre Droz, Pierre Fumoleau, Chris Twelves. Eur J Cancer 2005
81
21

Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma.
Christine M Heske, Mindy I Davis, Joshua T Baumgart, Kelli Wilson, Michael V Gormally, Lu Chen, Xiaohu Zhang, Michele Ceribelli, Damien Y Duveau, Rajarshi Guha,[...]. Clin Cancer Res 2017
28
21

NAD⁺ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study.
Shuraila F Zerp, Conchita Vens, Ben Floot, Marcel Verheij, Baukelien van Triest. Radiother Oncol 2014
24
21

Nicotinamide phosphoribosyltransferase in malignancy: a review.
Rodney E Shackelford, Kim Mayhall, Nicole M Maxwell, Emad Kandil, Domenico Coppola. Genes Cancer 2013
80
21


Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience.
Fabrizio Montecucco, Michele Cea, Inga Bauer, Debora Soncini, Irene Caffa, Denise Lasigliè, Aimable Nahimana, Antonio Uccelli, Santina Bruzzone, Alessio Nencioni. Curr Drug Targets 2013
38
21

Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data.
Anne von Heideman, Ake Berglund, Rolf Larsson, Peter Nygren. Cancer Chemother Pharmacol 2010
106
21

The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor.
Kyle Holen, Leonard B Saltz, Ellen Hollywood, Konrad Burk, Axel-Rainer Hanauske. Invest New Drugs 2008
181
21

Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway.
Jun Feng, Peng-Fei Yan, Hong-Yang Zhao, Fang-Cheng Zhang, Wo-Hua Zhao, Min Feng. Biomed Res Int 2016
28
21

QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study.
Nora Hinsch, Matthias Frank, Claudia Döring, Christian Vorländer, Martin-Leo Hansmann. BMC Cancer 2009
19
21

Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.
Simone M Goldinger, Sharon Gobbi Bischof, Regina Fink-Puches, Claus-Detlev Klemke, Brigitte Dréno, Martine Bagot, Reinhard Dummer. JAMA Dermatol 2016
18
21

A Phase I study of CHS 828 in patients with solid tumor malignancy.
Peter Hovstadius, Rolf Larsson, Elin Jonsson, Torsten Skov, Anne-Marie Kissmeyer, Klaus Krasilnikoff, Jonas Bergh, Mats O Karlsson, Anna Lönnebo, Johan Ahlgren. Clin Cancer Res 2002
81
21

Pervasive genetic interactions modulate neurodevelopmental defects of the autism-associated 16p11.2 deletion in Drosophila melanogaster.
Janani Iyer, Mayanglambam Dhruba Singh, Matthew Jensen, Payal Patel, Lucilla Pizzo, Emily Huber, Haley Koerselman, Alexis T Weiner, Paola Lepanto, Komal Vadodaria,[...]. Nat Commun 2018
22
14

Kctd13 deletion reduces synaptic transmission via increased RhoA.
Christine Ochoa Escamilla, Irina Filonova, Angela K Walker, Zhong X Xuan, Roopashri Holehonnur, Felipe Espinosa, Shunan Liu, Summer B Thyme, Isabel A López-García, Dorian B Mendoza,[...]. Nature 2017
57
14

Functional impact of global rare copy number variation in autism spectrum disorders.
Dalila Pinto, Alistair T Pagnamenta, Lambertus Klei, Richard Anney, Daniele Merico, Regina Regan, Judith Conroy, Tiago R Magalhaes, Catarina Correia, Brett S Abrahams,[...]. Nature 2010
14

A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders.
Flore Zufferey, Elliott H Sherr, Noam D Beckmann, Ellen Hanson, Anne M Maillard, Loyse Hippolyte, Aurélien Macé, Carina Ferrari, Zoltán Kutalik, Joris Andrieux,[...]. J Med Genet 2012
155
14

The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor proliferation and brain cytoarchitecture linked to the ERK MAPK pathway.
Joanna Pucilowska, Joseph Vithayathil, Emmanuel J Tavares, Caitlin Kelly, J Colleen Karlo, Gary E Landreth. J Neurosci 2015
84
14

Recurrent 16p11.2 microdeletions in autism.
Ravinesh A Kumar, Samer KaraMohamed, Jyotsna Sudi, Donald F Conrad, Camille Brune, Judith A Badner, T Conrad Gilliam, Norma J Nowak, Edwin H Cook, William B Dobyns,[...]. Hum Mol Genet 2008
466
14

The kynurenine pathway: a finger in every pie.
Jonathan Savitz. Mol Psychiatry 2020
120
14

Brain-derived neurotrophic factor and neuropsychiatric disorders.
Anita E Autry, Lisa M Monteggia. Pharmacol Rev 2012
743
14

The kynurenine pathway and the brain: Challenges, controversies and promises.
Robert Schwarcz, Trevor W Stone. Neuropharmacology 2017
139
14

Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.
Federica Gevi, Lello Zolla, Stefano Gabriele, Antonio M Persico. Mol Autism 2016
88
14

16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort.
Kyle J Steinman, Sarah J Spence, Melissa B Ramocki, Monica B Proud, Sudha K Kessler, Elysa J Marco, LeeAnne Green Snyder, Debra D'Angelo, Qixuan Chen, Wendy K Chung,[...]. Am J Med Genet A 2016
74
14


Pten regulates neuronal arborization and social interaction in mice.
Chang-Hyuk Kwon, Bryan W Luikart, Craig M Powell, Jing Zhou, Sharon A Matheny, Wei Zhang, Yanjiao Li, Suzanne J Baker, Luis F Parada. Neuron 2006
667
14

Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil.
Tie-Qiang Bi, Xiang-Ming Che, Xin-Hua Liao, Dan-Jie Zhang, Hou-Long Long, Hai-Jun Li, Wei Zhao. Oncol Rep 2011
85
14

Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer.
Jair Machado Espindola-Netto, Claudia C S Chini, Mariana Tarragó, Enfeng Wang, Shamit Dutta, Krishnendu Pal, Debabrata Mukhopadhyay, Mauro Sola-Penna, Eduardo N Chini. Oncotarget 2017
19
14

NAMPT inhibition synergizes with NQO1-targeting agents in inducing apoptotic cell death in non-small cell lung cancer cells.
Hui-Ying Liu, Qing-Ran Li, Xue-Fang Cheng, Guang-Ji Wang, Hai-Ping Hao. Chin J Nat Med 2016
10
20

Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells.
Ilirjana Bajrami, Asha Kigozi, Antoinette Van Weverwijk, Rachel Brough, Jessica Frankum, Christopher J Lord, Alan Ashworth. EMBO Mol Med 2012
74
14

Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal.
Mi Young Kim, Tong Zhang, W Lee Kraus. Genes Dev 2005
597
14


Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition.
Michele Cea, Antonia Cagnetta, Mariateresa Fulciniti, Yu-Tzu Tai, Teru Hideshima, Dharminder Chauhan, Aldo Roccaro, Antonio Sacco, Teresa Calimeri, Francesca Cottini,[...]. Blood 2012
97
14

Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells.
Gabriele Zoppoli, Michele Cea, Debora Soncini, Floriana Fruscione, Justine Rudner, Eva Moran, Irene Caffa, Davide Bedognetti, Giulia Motta, Riccardo Ghio,[...]. Exp Hematol 2010
42
14

Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities.
Hang Chen, Shiyu Wang, Haiyuan Zhang, Edouard C Nice, Canhua Huang. Expert Rev Anticancer Ther 2016
30
14

Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites.
Daniela Buonvicino, Francesca Mazzola, Federica Zamporlini, Francesco Resta, Giuseppe Ranieri, Emidio Camaioni, Mirko Muzzi, Riccardo Zecchi, Giuseppe Pieraccini, Christian Dölle,[...]. Cell Chem Biol 2018
29
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.